For the readers interested in the stock health of Sio Gene Therapies Inc. (SIOX). It is currently valued at $2.96. When the transactions were called off in the previous session, Stock hit the highs of $2.97, after setting-off with the price of $2.73. Company’s stock value dipped to $2.62 during the trading on the day. When the trading was stopped its value was $2.74.
Recently in News on December 15, 2020, Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of AXO-AAV-GM1 for GM1 Gangliosidosis. – Generally well-tolerated with a favorable safety profile in five patients- Serum beta-galactosidase enzyme activity increased in all patients at all timepoints between Day 7 and Month 6, representing an approximate doubling in enzyme activity after gene transfer- At Month 6, enzyme activity restored to 23-57% (mean: 38%) of normal reference levels- All five children demonstrated signs of clinical disease stability as assessed by Vineland-3 Growth Scale Value, Upright and Floor Mobility, and Clinical Global Impression (CGI) scales- High-dose cohort initiated in November 2020; two patients now dosed without complications. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Sio Gene Therapies Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.74 on 10/05/20, with the lowest value was $1.41 for the same time period, recorded on 03/18/20.
Sio Gene Therapies Inc. (SIOX) full year performance was -44.47%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Sio Gene Therapies Inc. shares are logging -48.43% during the 52-week period from high price, and 109.93% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.41 and $5.74.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1303465 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Sio Gene Therapies Inc. (SIOX) recorded performance in the market was -42.19%, having the revenues showcasing -30.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 151.88M, as it employees total of 38 workers.
Market experts do have their say about Sio Gene Therapies Inc. (SIOX)
During the last month, 5 analysts gave the Sio Gene Therapies Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.14, with a change in the price was noted -0.01. In a similar fashion, Sio Gene Therapies Inc. posted a movement of -0.34% for the period of last 100 days, recording 2,064,373 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SIOX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Sio Gene Therapies Inc. (SIOX)
Raw Stochastic average of Sio Gene Therapies Inc. in the period of last 50 days is set at 48.03%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 38.34%. In the last 20 days, the company’s Stochastic %K was 32.82% and its Stochastic %D was recorded 34.65%.
Bearing in mind the latest performance of Sio Gene Therapies Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -42.19%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -4.21%, alongside a downfall of -44.47% for the period of the last 12 months. The shares increased approximately by -4.52% in the 7-day charts and went down by 28.14% in the period of the last 30 days. Common stock shares were lifted by -30.84% during last recorded quarter.